127 related articles for article (PubMed ID: 29109759)
21. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
22. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
24. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
25. Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification.
Jiang T; Zheng L; Li X; Liu J; Song H; Xu Y; Dong C; Liu L; Wang H; Wang S; Wang R; Song J
Front Cell Dev Biol; 2021; 9():678770. PubMed ID: 34858968
[No Abstract] [Full Text] [Related]
26. MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2.
Yu Y; Cai O; Wu P; Tan S
J Cell Biochem; 2019 Jan; 120(1):967-976. PubMed ID: 30206962
[TBL] [Abstract][Full Text] [Related]
27. HIWI expression profile in cancer cells and its prognostic value for patients with colorectal cancer.
Zeng Y; Qu LK; Meng L; Liu CY; Dong B; Xing XF; Wu J; Shou CC
Chin Med J (Engl); 2011 Jul; 124(14):2144-9. PubMed ID: 21933617
[TBL] [Abstract][Full Text] [Related]
28. ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Wang J; Yang S; Min L; Zhu S; Guo S; Zhang S
Front Oncol; 2020; 10():589241. PubMed ID: 33634019
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.
Wang HB; Yan HC; Liu Y
Clin Transl Oncol; 2016 Jul; 18(7):735-42. PubMed ID: 26497353
[TBL] [Abstract][Full Text] [Related]
30. Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.
Chen Z; Liu J; Zhang Y
Med Sci Monit; 2017 Aug; 23():3861-3868. PubMed ID: 28794404
[TBL] [Abstract][Full Text] [Related]
31. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
Li J; Li Y; Liu H; Liu Y; Cui B
PLoS One; 2017; 12(5):e0178515. PubMed ID: 28562687
[TBL] [Abstract][Full Text] [Related]
32. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
33. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
34. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
[TBL] [Abstract][Full Text] [Related]
35. miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer.
Gao SJ; Chen L; Lu W; Zhang L; Wang L; Zhu HH
Oncol Lett; 2018 Jun; 15(6):9101-9109. PubMed ID: 29928331
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
37. Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.
Shao W; Wang Q; Wang F; Jiang Y; Xu M; Xu J
Onco Targets Ther; 2016; 9():477-87. PubMed ID: 26889086
[TBL] [Abstract][Full Text] [Related]
38. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
[TBL] [Abstract][Full Text] [Related]
39. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
40. ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma.
Peng S; Wang J; Hei N; Cui Z
J Cancer; 2024; 15(13):4156-4174. PubMed ID: 38947403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
